In 2020, face-to-face detailing marketing, when a pharmaceutical representative visits a hospital, was the most common promotional technique used by 71 percent of pharmaceutical companies in the CIS region. E-meetings were used in only five percent of the cases.
Distribution of promotional volume in the pharmaceutical industry in the Commonwealth of Independent States (CIS) in 2020, by channel
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you
Global overview
6
- Premium Statistic Top global biotech companies - net sales 2021
- Premium Statistic Top global biotech companies based on number of employees 2022
- Premium Statistic Dedicated biotechnology company number comparison by select country 2020
- Basic Statistic Total number of biotechnology companies in Europe 2020
- Premium Statistic Biotechnology R&D expenditure in selected countries 2020
- Basic Statistic Biotechnology R&D intensity in enterprise sector by country 2020
Main figures
6
- Basic Statistic Production value of the Spanish biotech sector 2010-2020
- Basic Statistic Production value of the Spanish biotech sector in relation to GDP 2010-2020
- Premium Statistic Employees in internal R&D biotechnology activities Spain 2009-2020
- Premium Statistic Biotechnology researchers in internal R&D in Spain 2009-2020
- Premium Statistic Biotech facilities in Spain 2020, by region
- Premium Statistic Main problems for biotechnology development in Spain 2020
Companies
6
- Premium Statistic Companies performing biotechnology activities Spain in 2020, by relevance
- Premium Statistic Biotech enterprises in Spain 2020, by size
- Premium Statistic Biotech enterprises in Spain 2020, by region
- Premium Statistic Average turnover of biotech enterprises in Spain 2020, by region
- Premium Statistic Percentage distribution of turnover of biotech enterprises in Spain 2020, by region
- Premium Statistic Leading Spanish companies in R&D on biotechnology 2020
Areas of application
6
- Premium Statistic Patent applications from Spain to the EPO in 2021, by field of technology
- Premium Statistic Share of biotechnology companies in Spain 2020, by sector
- Premium Statistic Share of companies performing R&D biotech activities in Spain 2020, by field
- Premium Statistic Biotech projects on medicines in development in Spain 2023, by therapeutic area
- Premium Statistic Diagnostics and personalized medicine projects in Spain 2023, by therapeutic area
- Premium Statistic Biotech projects in development in Spain 2023, by therapeutic area
R&D investment
6
- Premium Statistic Internal investment in R&D activities in biotechnology in Spain 2009-2020
- Premium Statistic R&D spending on biotech activities made by companies in Spain 2009-2020
- Premium Statistic R&D spending on biotech activities made by the government in Spain 2009-2020
- Premium Statistic Biotechnology industry current expenses in Spain 2020, by nature of the expense
- Premium Statistic Biotechnology capital expenses in Spain 2020, by type
- Basic Statistic Biotechnology investment by origin of funds in Spain 2020
Funding
6
- Premium Statistic R&D intensity in the biotechnology business sector in Spain 2010-2020
- Premium Statistic R&D intensity in the biotech business sector as share of industry value added Spain
- Basic Statistic Private capital increases in Spanish biotech companies 2016-2021
- Basic Statistic Largest private capital increases Spanish biotech companies 2021
- Basic Statistic Capital increases in publicly traded Spanish biotech companies 2016-2020
- Basic Statistic Capital increases in publicly traded biotech companies in Spain 2020, by company
Further related statistics
16
- Net ingredient cost of top chemical substances dispensed in England 2021
- Average per-patient biopharmaceutical clinical trial costs in the U.S. 2013, by phase
- Revenues share of biopharmaceuticals in Germany 2009 to 2013 by therapeutic area
- States with the most biopharmaceutical clinical trials in the U.S. in 2013
- Celltrion R&D investment South Korea 2013-2017
- Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Average peak sales forecast per new biopharmaceutical asset 2013-2022
- Biosimilar market size Japan 2018-2030
- Number of biopharmaceutical clinical trial participants in the U.S. 2013, by phase
- Biopharmaceuticals market value in Latin America 2022-2027
- Number of biopharmaceutical clinical trials in the U.S. 2013, by selected disease
- Factors impacting valuation of biopharma companies per executives 2020
- U.S. medicinal chemicals and botanical products ad spend 2020-2021
- Panama: vitamins import value 2014-2017
- Ecuador: vitamins export value 2014-2017
Further Content: You might find this interesting as well
Statistics
- Net ingredient cost of top chemical substances dispensed in England 2021
- Average per-patient biopharmaceutical clinical trial costs in the U.S. 2013, by phase
- Revenues share of biopharmaceuticals in Germany 2009 to 2013 by therapeutic area
- States with the most biopharmaceutical clinical trials in the U.S. in 2013
- Celltrion R&D investment South Korea 2013-2017
- Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Average peak sales forecast per new biopharmaceutical asset 2013-2022
- Biosimilar market size Japan 2018-2030
- Number of biopharmaceutical clinical trial participants in the U.S. 2013, by phase
- Biopharmaceuticals market value in Latin America 2022-2027
- Number of biopharmaceutical clinical trials in the U.S. 2013, by selected disease
- Factors impacting valuation of biopharma companies per executives 2020
- U.S. medicinal chemicals and botanical products ad spend 2020-2021
- Panama: vitamins import value 2014-2017
- Ecuador: vitamins export value 2014-2017
IQVIA. (March 24, 2021). Distribution of promotional volume in the pharmaceutical industry in the Commonwealth of Independent States (CIS) in 2020, by channel [Graph]. In Statista. Retrieved June 05, 2023, from https://www.statista.com/statistics/1236589/pharma-promotion-share-in-cis/
IQVIA. "Distribution of promotional volume in the pharmaceutical industry in the Commonwealth of Independent States (CIS) in 2020, by channel ." Chart. March 24, 2021. Statista. Accessed June 05, 2023. https://www.statista.com/statistics/1236589/pharma-promotion-share-in-cis/
IQVIA. (2021). Distribution of promotional volume in the pharmaceutical industry in the Commonwealth of Independent States (CIS) in 2020, by channel . Statista. Statista Inc.. Accessed: June 05, 2023. https://www.statista.com/statistics/1236589/pharma-promotion-share-in-cis/
IQVIA. "Distribution of Promotional Volume in The Pharmaceutical Industry in The Commonwealth of Independent States (Cis) in 2020, by Channel ." Statista, Statista Inc., 24 Mar 2021, https://www.statista.com/statistics/1236589/pharma-promotion-share-in-cis/
IQVIA, Distribution of promotional volume in the pharmaceutical industry in the Commonwealth of Independent States (CIS) in 2020, by channel Statista, https://www.statista.com/statistics/1236589/pharma-promotion-share-in-cis/ (last visited June 05, 2023)
Distribution of promotional volume in the pharmaceutical industry in the Commonwealth of Independent States (CIS) in 2020, by channel [Graph], IQVIA, March 24, 2021. [Online]. Available: https://www.statista.com/statistics/1236589/pharma-promotion-share-in-cis/